TLDR
- Prenetics Global raised $48 million in an oversubscribed equity round to support its Bitcoin treasury and expansion of the IM8 supplement brand.
- The funding attracted prominent cryptocurrency investors, including Kraken, Exodus, and Jihan Wu’s GPTX, as well as sports and business figures.
- Prenetics Global’s Bitcoin holdings now include approximately 275 BTC, valued at around $31 million, with plans to grow its liquidity.
- The company aims to reach $1 billion in annual revenue and $1 billion in Bitcoin holdings within the next five years.
- Prenetics Global’s IM8 brand generated $100 million in recurring revenue within its first year and projects up to $200 million in 2026.
Prenetics Global, a health sciences firm listed on Nasdaq, raised $48 million in an oversubscribed equity round. The funds will support the company’s Bitcoin treasury strategy and expand its supplement brand IM8. The offering attracted a range of crypto-focused investors.
Prenetics Global Attracts Crypto-Focused Investors
Prenetics Global secured the new funding from investors such as Kraken, Exodus, GPTX by Jihan Wu, and DL Holdings. Other investors in the round include tennis player Aryna Sabalenka and Hong Kong tycoon Adrian Cheng. These investors increased their stakes in the company alongside Prenetics’ existing shareholders, including football legend David Beckham.
The total gross proceeds from the offering are expected to be around $48 million. If all warrants are exercised, Prenetics Global could raise up to $216 million in total proceeds. The new capital will enable the company to accelerate its Bitcoin treasury strategy and expand its IM8 supplement brand globally.
Bitcoin Treasury Strategy and IM8 Brand Expansion
Prenetics Global announced its Bitcoin treasury initiative in June, beginning a daily 1 BTC accumulation strategy. As of October 27, the company’s holdings comprise approximately 275 BTC, valued at around $31 million. Following the latest equity offering, Prenetics expects to have a liquidity position of around $131 million.
IM8, Prenetics’ supplement brand co-founded with Beckham, achieved $100 million in recurring revenue within 11 months. The company projects revenues of between $160 million and $200 million for IM8 in 2026. CEO Danny Yeung stated that the company’s long-term ambition is to reach $1 billion in annual revenue, with an equal target of $1 billion in Bitcoin holdings over the next five years.
Following the offering, Prenetics Global’s stock dropped 21.96% to close at $13.08 on Monday. However, it rebounded 4.51% in after-hours trading. Despite a 19.46% drop over the past five days, Prenetics’ stock has increased by 161.6% over the last six months.


